本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aligos Therapeutics, Inc.

5.53
+0.19003.56%
盘后:5.530.00000.00%19:30 EDT
成交量:5.73万
成交额:31.27万
市值:3,453.26万
市盈率:-0.76
高:5.64
开:5.50
低:5.30
收:5.34
52周最高:13.69
52周最低:3.98
股本:624.46万
流通股本:368.17万
量比:2.25
换手率:1.56%
股息:- -
股息率:- -
每股收益(TTM):-7.3016
每股收益(LYR):-2.4500
净资产收益率:-113.59%
总资产收益率:-49.12%
市净率:1.08
市盈率(LYR):-2.26

数据加载中...

2021/06/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/05/03

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/27

重要事件披露

8-K - Current report
2021/03/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/23

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/25

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/30

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/10/28

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/22

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/10/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/20

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans